
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : RB-190
Therapeutic Area : Neurology
Study Phase : IND Enabling
Recipient : Suven Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Right Brain Bio Signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190
Details : The agreement aims for the production of its lead drug candidate, RB-190, targeting the root cause of Parkinson's disease.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 11, 2025
Lead Product(s) : RB-190
Therapeutic Area : Neurology
Highest Development Status : IND Enabling
Recipient : Suven Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
